Suzhou Zelgen Biopharmaceuticals Co., Ltd. (688266.SS) SHH

101.49

-1.21(-1.18%)

Updated at October 17 03:00PM

Currency In CNY

Valuation

Market Cap16.52B
Enterprise Value15.39B
P/E Ratio-180.96
PEG Ratio12.41
Price/Sales Ratio40.22
Price/Book Ratio22.16
Enterprise/Revenue38.72
Enterprise/EBITDA-206

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-0.22
Operating Margin-0.23

Management Effectiveness

Return On Assets-0.05
Return On Equity-0.12

Income Statement

Revenue532.95M
Revenue/Share2.6
Gross Profit495.23M
EBITDA-174.1M
Net Income-137.83M
Diluted EPS-0.52

Balance Sheet

Total Cash2.15B
Total Cash/Share8.37
Total Debt1.12B
Total Debt/Equity0.95
Current Ratio1.9
Book Value Per Share4.58

Price History

52-Week Change50
52-Week High134.17
52-Week Low58
Moving Average 50 Days108.45
Moving Average 200 Days99.2

Statistics

Average Volume4.47M
Shares Outstanding264.71M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-0.17
Last Split FactorN/A
Last Split DateN/A